<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE ArticleSet PUBLIC "-//NLM//DTD PubMed 2.7//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/in/PubMed.dtd">
<ArticleSet>
<Article>
<Journal>
				<PublisherName>West Asia Organization for Cancer Prevention (WAOCP), APOCP's West Asia Chapter.</PublisherName>
				<JournalTitle>Asian Pacific Journal of Cancer Prevention</JournalTitle>
				<Issn>1513-7368</Issn>
				<Volume>14</Volume>
				<Issue>9</Issue>
				<PubDate PubStatus="epublish">
					<Year>2013</Year>
					<Month>09</Month>
					<Day>01</Day>
				</PubDate>
			</Journal>
<ArticleTitle>BCRP Expression in VX2 Rabbit Liver Tumours and its Effects on Tumour Recurrence, Metastasis and Treatment Tolerability</ArticleTitle>
<VernacularTitle></VernacularTitle>
			<FirstPage>5089</FirstPage>
			<LastPage>5093</LastPage>
			<ELocationID EIdType="pii">28082</ELocationID>
			
			
			<Language>EN</Language>
<AuthorList>
</AuthorList>
				<PublicationType>Journal Article</PublicationType>
			<History>
				<PubDate PubStatus="received">
					<Year>1970</Year>
					<Month>01</Month>
					<Day>01</Day>
				</PubDate>
			</History>
		<Abstract>&lt;br/&gt;&lt;b&gt;Objective&lt;/b&gt;: This study aimed to investigate the effects of BCRP expression on tumor recurrence, metastasisand treatment tolerability. &lt;br/&gt;&lt;b&gt;Methods&lt;/b&gt;: A VX2 rabbit liver tumor model was established. Division was randomlyinto 4 groups: namely saline control group; A group, given hydration lipiodol; B group, Ad-p53; and C group,Ad-p53+hydration lipiodol. After the intervention, samples were collected to detect the BCRP, MMP-2, VEGFand PCNA. &lt;br/&gt;&lt;b&gt;Results&lt;/b&gt;: The expression of BCRP, MMP-2, PCNA and VEGF in tumors in Group A had no significantdifference when compared with the control group, while in B and C group, the values were significantly lower(P &lt; 0.05). BCRP positive expression in metastatic lesions significantly increased (P &lt; 0.05), and was correlatedwith MMP-2 (X2=6.172, P = 0.0131). &lt;br/&gt;&lt;b&gt;Conclusions&lt;/b&gt;: BCRP may play an important role in mediating liver cancermultidrug resistance to chemotherapy, and may be correlated with tumor recurrence and metastasis, whichleads to weakened treatment effect. Ad-P53 can down-regulate the expression of related genes, playing a role inmultidrug resistance reversal and increased sensitivity in liver cancer treatment.</Abstract>
		<ObjectList>
			<Object Type="keyword">
			<Param Name="value">VX2 rabbit liver tumor</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">intervention</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">BCRP</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">MMP-2</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">VEGF</Param>
			</Object>
			<Object Type="keyword">
			<Param Name="value">PCNA</Param>
			</Object>
		</ObjectList>
<ArchiveCopySource DocType="pdf">https://journal.waocp.org/article_28082_1937f7e7d9b9667585d85f6443a86b58.pdf</ArchiveCopySource>
</Article>
</ArticleSet>
